InsiderTrades

Form 4 for PROK PROKIDNEY CORP.

Accepted 2026-06-15 17:32:30 ET · period of report 2026-06-12 · accession 0001193125-26-271337 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-15 17:32 2026-06-12 PROK Girolamo Todd C CLO C - Cnv Deriv $0.00 +163.9K 327.7K +100% $0
DM 2026-06-15 17:32 2026-06-12 PROK Girolamo Todd C CLO C - Cnv Deriv $0.00 -327.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-06-12 C A 163,857 $0.00 327,713 D — —
2 Derivative Class B Common Stock 2026-06-12 C D 163,857 $0.00 0 D $0.00 · — to — 163,857 Class A Common Stock (F1) The Class B Common Stock and the Common Units in ProKidney Holdings LLC (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Amended and Restated Exchange Agreement, dated as of July 1, 2025, and and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, LLC, each Class B Common Stock, together with a paired Common Unit, may be exchanged for Class A Common stock on a one-for-one basis. (F2) The Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Stock do not expire. (F2) The Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Stock do not expire.
3 Derivative Common Units in ProKidney Holdings, LLC 2026-06-12 C D 163,857 $0.00 0 D $0.00 · — to — 163,857 Class A Common Stock (F3) The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire. (F3) The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.